Welcome to LookChem.com Sign In|Join Free

CAS

  • or

65271-75-2

Post Buying Request

65271-75-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

65271-75-2 Usage

Family

Anthraquinone

Source

Synthetic chemical compound derived from anthracene-9,10-dione

Potential Application

Anti-cancer agent

Mechanism of Action

Inhibits cancer cell growth by inducing apoptosis and disrupting the cell cycle

Additional Potential

Photosensitizer for photodynamic therapy

Current Status

Research ongoing, not approved for clinical use

Check Digit Verification of cas no

The CAS Registry Mumber 65271-75-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,2,7 and 1 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 65271-75:
(7*6)+(6*5)+(5*2)+(4*7)+(3*1)+(2*7)+(1*5)=132
132 % 10 = 2
So 65271-75-2 is a valid CAS Registry Number.

65271-75-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,4-bis(5-hydroxypentylamino)anthracene-9,10-dione

1.2 Other means of identification

Product number -
Other names 1,4-bis[(5-hydroxypentyl)amino]anthracene-9,10-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:65271-75-2 SDS

65271-75-2Downstream Products

65271-75-2Relevant articles and documents

Synthesis of mono- and bis-substituted anthraquinones as inhibitors of human telomerase

Gibson,Anderson,Jenkins,Cairns

, p. 669 - 671 (2007/10/03)

A number of anthraquinone derivatives have been synthesized in good yield and tested for their ability to inhibit the enzymes telomerase and Taq polymerase using a modified telomeric repeat amplification protocol. In addition, all the synthesized compounds were screened against a panel of ovarian carcinoma cell lines (A2780, CH1 and SKOV-3) to determine their cytotoxicity. All compounds tested inhibited telomerase at a concentration of 10 μM, but showed negligible inhibition of Taq polymerase. None of the compounds tested displayed significant general cell toxicity in ovarian cancer cell lines. The synthesized compounds are potential selective inhibitors of human telomerase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 65271-75-2